650 filings
Page 15 of 33
8-K
ehunrt4
24 Sep 15
OncoGenex Announces Phase 2 Rainier Results in Previously Untreated Metastatic
12:00am
S-8
1nh872kr1x pplrzrz
25 Aug 15
Registration of securities for employees
12:00am
8-K
kjttbh
13 Aug 15
OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Second Quarter 2015
12:00am
8-K
ngpb2igji3kyungcg mz
13 Jul 15
OncoGenex Announces Custirsen Phase 3 “ENSPIRIT” Trial Continues Following Completion of
12:00am
8-K
xzse7q4xe3
22 May 15
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
dkbgwxn
14 May 15
OncoGenex Pharmaceuticals, Inc. Reports Financial Results for First Quarter 2015
12:00am
8-K
pw2f1
30 Apr 15
OncoGenex Announces Share Purchase Agreement with Lincoln Park Capital Fund, LLC
12:00am
424B5
r1ufzdi1
30 Apr 15
Prospectus supplement for primary offering
12:00am
8-K
qecg h4asg
27 Apr 15
Entry into a Material Definitive Agreement
12:00am
8-K
r5cu7y
26 Mar 15
OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014
12:00am
8-K
wyde88me10ge xj16
12 Feb 15
Entry into a Material Definitive Agreement
12:00am
8-K
o054pq
30 Dec 14
Entry into a Material Definitive Agreement
12:00am
8-K
9w9amki18cys4t6
19 Dec 14
OncoGenex Announces Results from the Phase 2 Borealis-1™ Trial of Apatorsen in the Treatment of Metastatic Bladder Cancer
12:00am